The Cannabinoid WIN 55,212-2 Prevents Neuroendocrine Differentiation of LNCaP Prostate Cancer Cells

Prostate Cancer and Prostatic Diseases - United Kingdom
doi 10.1038/pcan.2016.19
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Autophagy Pathway Is Required for IL-6 Induced Neuroendocrine Differentiation and Chemoresistance of Prostate Cancer LNCaP Cells

PLoS ONE
Multidisciplinary
2014English

Cannabinoid Agonist WIN-55,212-2 Partially Restores Neurogenesis in the Aged Rat Brain

Molecular Psychiatry
PsychiatryMolecular NeuroscienceMental HealthMolecular BiologyCellular
2009English

WIN 55,212-2 Decreases the Reinforcing Actions of Cocaine Through CB1 Cannabinoid Receptor Stimulation

Behavioural Brain Research
Behavioral Neuroscience
2003English

Gestational Exposure to the Cannabinoid WIN 55,212-2 and Its Effect on the Innate Intestinal Immune Response

Scientific Reports
Multidisciplinary
2019English

Cannabinoid Receptor Agonist-Induced Apoptosis of Human Prostate Cancer Cells LNCaP Proceeds Through Sustained Activation of ERK1/2 Leading to G1Cell Cycle Arrest

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2006English

Cannabinoid WIN-55,212-2 Mesylate Inhibits ADAMTS-4 Activity in Human Osteoarthritic Articular Chondrocytes by Inhibiting Expression of Syndecan-1

Molecular Medicine Reports
OncologyGeneticsMolecular BiologyBiochemistryCancer ResearchMolecular Medicine
2016English

Involvement of the CB2 Cannabinoid Receptor in Cell Growth Inhibition and G0/G1 Cell Cycle Arrest via the Cannabinoid Agonist WIN 55,212–2 in Renal Cell Carcinoma

BMC Cancer
Cancer ResearchOncologyGenetics
2018English

Prostate Cancer and Neuroendocrine Differentiation: More Neuronal, Less Endocrine?

Frontiers in Oncology
Cancer ResearchOncology
2015English

Is HOTAIR Really Involved in Neuroendocrine Prostate Cancer Differentiation?

Epigenomics
Cancer ResearchGenetics
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy